Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 1,562 | 0 | 1,573 | 1,536 | 1,211 |
| Cost of Goods | 1,038 | N/A | 964 | 1,005 | 946 |
| Gross Profit | 524 | N/A | 609 | 531 | 265 |
| Operating Expenses | 2,080 | 0 | 2,912 | -1,000 | 2,763 |
| Operating Income | -1,518 | N/A | -1,339 | -1,468 | -1,552 |
| Other Income | 10 | 0 | 7 | 5 | 6 |
| Pre-tax Income | -1,508 | 0 | -1,332 | -1,463 | -1,546 |
| Net Income Continuous | -1,508 | N/A | -1,332 | N/A | -1,546 |
| Net Income | $-1,508 | $N/A | $-1,332 | $N/A | $-1,546 |
| EPS Basic Total Ops | -0.20 | N/A | -0.20 | -0.30 | -0.30 |
| EPS Basic Continuous Ops | -0.23 | N/A | -0.24 | N/A | -0.28 |
| EPS Diluted Total Ops | -0.20 | N/A | -0.20 | -0.30 | -0.30 |
| EPS Diluted Continuous Ops | -0.23 | N/A | -0.24 | N/A | -0.28 |
| EBITDA(a) | $-1,518 | $N/A | $-1,224 | $1,588 | $-1,552 |